Ignite Creation Date:
2025-12-26 @ 10:34 AM
Ignite Modification Date:
2025-12-31 @ 8:18 PM
Study NCT ID:
NCT04710628
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-07-02
First Post:
2020-12-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Combination of Pembrolizumab and Lenvatinib, in Pre-treated Thymic CArcinoma paTIents
Sponsor:
MedSIR
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09-21
Start Date Type:
ACTUAL
Primary Completion Date:
2024-07-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-01-31
Completion Date Type:
ESTIMATED
First Submit Date:
2020-12-03
First Submit QC Date:
None
Study First Post Date:
2021-01-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-27
Last Update Post Date:
2025-07-02
Last Update Post Date Type:
ACTUAL